IDPC and GDPO unpick key issues raised by the 2019 World Drug Report through the lens of public health, including the expansion of regulated cannabis markets, the non-medical use of tramadol in Africa and challenges related to data-collection.
Government, civil society and community representatives discussed the state of play of debates in Vienna as well as developments in the field of human rights, development, public health and novel trends.
This report provides the most recent data on the use of pretrial detention in Latin America, looks specifically at its impact on women, and concludes with recommendations to reduce the number of women in pretrial detention.
While we acknowledge that the statement represents limited progress in some areas, we regret that it repeats the mistakes of the past and was negotiated in the absence of a genuine and honest evaluation of the past decade, since the adoption of the 2009 Political Declaration and Action Plan on…
IDPC evaluates the impacts of drug policies implemented in Asia over the past decade, assessing progress made towards international and regional goals and concluding on the need to move away from the damaging drug-free approach.
IDPC outlines the key drug policy developments in India since the UNGASS Outcome Document was adopted in 2016, which highlights health and human rights concerns in relation to both drugs and drug policies.
IDPC discusses the alarming scale of the negative health impacts related to drug use described in the 2018 World Drug Report, but also the woefully inadequate provision of a range of scientifically proven interventions to counter these.
IDPC outlines the key issues for consideration by member states as they reflect on what has been achieved since the adoption of the 2009 Political Declaration and Plan of Action and the implications for the next phase of the international drug policy regime.